13F-HR filed by Artal Group S.A.
Artal Group S.A. filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-10, with 104 holding rows worth $4,705,099,000.
- Accession
- 0001053906-18-000011
- Filer
- CIK 1053906
- Filed
- 2018-08-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 106 entries on the cover page, a total value of $4,705,099,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,705,099,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerStichting Administratiekantoor Westend028-15028
- included managerWestend S.A.028-15029
- included managerArtal International Management S.A.028-15031
- included managerArtal International S.C.A.028-15033
- included managerInvus Public Equities Advisors, LLC028-11522
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WEIGHT WATCHERS INTL INC | 948626106 | COM | 20,818,300 | $2,104,730,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 60,240,864 | $722,891,000 | thousands by filing date | |
| Bank of America Corp | 060505104 | COM | 6,350,000 | $179,007,000 | thousands by filing date | call |
| CELGENE CORP | 151020104 | COM | 2,000,000 | $158,840,000 | thousands by filing date | call |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 675,000 | $103,768,000 | thousands by filing date | |
| Morgan Stanley | 617446448 | COM | 1,500,000 | $71,100,000 | thousands by filing date | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,250,000 | $69,175,000 | thousands by filing date | call |
| Goldman Sachs Group,Inc. | 38141G104 | COM | 300,000 | $66,171,000 | thousands by filing date | call |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 650,000 | $64,019,000 | thousands by filing date | |
| GENERAL MTRS CO COM | 37045V100 | Stock | 1,500,000 | $59,100,000 | thousands by filing date | call |
| Wells Fargo & Company | 949746101 | COM | 1,000,000 | $55,440,000 | thousands by filing date | call |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 450,000 | $49,419,000 | thousands by filing date | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,000,000 | $48,520,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,900,000 | $45,298,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 700,000 | $44,436,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 900,000 | $43,947,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 2,396,040 | $37,378,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 1,000,000 | $36,750,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 800,000 | $35,576,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 2,000,000 | $33,560,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 350,000 | $29,481,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 170,000 | $26,682,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 700,000 | $25,690,000 | thousands by filing date | call |
| ZOGENIX INC. | 98978L204 | Common Stock | 500,000 | $22,100,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,700,000 | $19,278,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 200,000 | $18,840,000 | thousands by filing date | call |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 500,000 | $17,750,000 | thousands by filing date | |
| FREEPORT MCMORAN INC CL B | 35671D857 | Stock | 1,000,000 | $17,260,000 | thousands by filing date | call |
| Inflarx Nv | N44821101 | COM | 500,000 | $16,125,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 100,000 | $15,653,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 250,000 | $15,650,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 350,000 | $15,565,000 | thousands by filing date | call |
| XENCOR INC | 98401F105 | COMMON STOCK | 400,000 | $14,804,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 400,000 | $14,680,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 300,000 | $14,649,000 | thousands by filing date | call |
| ANAPTYSBIO INC | 032724106 | COM | 200,000 | $14,208,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 525,000 | $14,065,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 50,000 | $13,985,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 200,000 | $12,696,000 | thousands by filing date | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 150,000 | $12,429,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 1,200,000 | $12,276,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 500,000 | $11,150,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 500,000 | $11,150,000 | thousands by filing date | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,500,000 | $10,950,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 150,000 | $10,763,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 500,000 | $10,760,000 | thousands by filing date | call |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 800,000 | $10,736,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 100,000 | $9,849,000 | thousands by filing date | call |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 200,000 | $9,040,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 236,000 | $9,018,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 700,000 | $8,960,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 250,000 | $8,908,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 400,000 | $7,852,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 50,000 | $7,848,000 | thousands by filing date | call |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 500,000 | $7,810,000 | thousands by filing date | call |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 500,000 | $7,625,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 250,000 | $7,293,000 | thousands by filing date | |
| VITAL THERAPIES INC | 92847R104 | COM | 1,000,000 | $6,850,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 500,000 | $6,625,000 | thousands by filing date | |
| AERPIO PHARMACEUTICALS INC | 00810B105 | COM | 1,558,400 | $6,467,000 | thousands by filing date | |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 400,000 | $6,420,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 500,000 | $6,325,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,750,000 | $6,243,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 600,000 | $5,592,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 400,000 | $5,260,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 425,000 | $5,206,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 350,000 | $5,135,000 | thousands by filing date | |
| RESTORBIO INC | 76133L103 | COM | 550,000 | $5,033,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 100,000 | $4,852,000 | thousands by filing date | call |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 475,000 | $4,741,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 100,000 | $4,547,000 | thousands by filing date | call |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 50,000 | $4,212,000 | thousands by filing date | call |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 216,879 | $4,147,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 250,000 | $4,033,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 400,000 | $3,932,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 550,000 | $3,850,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 100,000 | $3,825,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 250,000 | $3,813,000 | thousands by filing date | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 300,000 | $3,672,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 2,750,000 | $3,630,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 125,000 | $3,570,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 500,000 | $3,535,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E103 | COM | 500,000 | $3,205,000 | thousands by filing date | |
| UNITY BIOTECHNOLOGY INC | 91381U101 | COM | 200,000 | $3,012,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 100,000 | $2,990,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 50,000 | $2,938,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 200,000 | $2,840,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 200,000 | $2,700,000 | thousands by filing date | |
| CLEMENTIA PHARMACEUTICALS IN | 185575107 | COM | 200,000 | $2,632,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 90,000 | $2,462,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 500,000 | $2,380,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 150,000 | $2,231,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 400,000 | $2,120,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 100,000 | $2,040,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 100,000 | $1,735,000 | thousands by filing date | |
| SIENNA BIOPHARMACEUTICALS IN | 82622H108 | COM | 99,000 | $1,504,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 150,000 | $1,380,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 256,400 | $944,000 | thousands by filing date | |
| TOCAGEN INC | 888846102 | COM | 100,000 | $934,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 150,000 | $900,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 500,000 | $670,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 500,000 | $455,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 60,697 | $426,000 | thousands by filing date | |
| ONCOCYTE CORP | 68235C107 | COM | 150,000 | $383,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001053906-18-000011 | this filing | 2018-08-10 | acceptance time not in the bulk data set |